Bernstock, J. D., Bag, A. K., Fiveash, J., Kachurak, K., Elsayed, G., Chagoya, G., . . . Friedman, G. K. (2020). Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors. Hum Gene Ther.
Chicago ZitierstilBernstock, Joshua D., et al. "Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors." Hum Gene Ther 2020.
MLA ZitierstilBernstock, Joshua D., et al. "Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors." Hum Gene Ther 2020.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.